Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNU6-524P** is annotated as **RNA, U6 small nuclear 524, pseudogene**, representing a non-coding RNA pseudogene related to the canonical U6 small nuclear RNA (snRNA), a component of the spliceosomal machinery. As a pseudogene, RNU6-524P is typically nonfunctional and does not produce a protein or participate in RNA splicing. In contrast, the canonical U6 snRNA is an essential catalytic RNA involved in pre-mRNA splicing and is highly conserved and functionally crucial across eukaryotes. The existence of many U6-derived pseudogenes in vertebrate genomes is well established, reflecting the evolutionary importance of the parent gene; however, these pseudogenes generally do not have known coding capacity or direct biological function. There is no evidence to suggest that RNU6-524P or similar snRNA pseudogenes function as therapeutic targets, participate in regulatory networks, or are involved in disease processes. No approved drugs target this or other snRNA pseudogenes, nor are they used as biomarkers. It is likely this entry refers only to a genomic locus lacking known functional or pharmacological relevance, hence **not a validated molecular target for therapeutic modulation**. **Key clarification:** - This is not a protein, receptor, enzyme, or functional non-coding RNA, but a **pseudogene**. - Pseudogenes are genomic DNA sequences similar to normal genes but are usually non-functional; in this case, derived from U6 snRNA, which is a part of the spliceosome. - The canonical, functional version is "U6 small nuclear RNA" or "U6 snRNA". - If you need information on the **active form (U6 snRNA)**, it is a non-protein coding RNA vital for pre-mRNA splicing. Pseudogenes such as RNU6-524P, by definition, lack this activity. **Summary of core issues:** - Entry is not a valid target for drug discovery or biomarker development. - It is a genomic artifact/pseudogene, not a functional biological entity. - If this entry appeared as a therapeutic "target," it is likely an annotation or database error.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 524, pseudogene (RNU6-524P).